Literature DB >> 3321589

Improvement of kidney transplant regraft results by using trauma death donors.

J M Cecka1, P I Terasaki.   

Abstract

Patients who have lost a transplanted kidney are widely recognized as high-risk patients for retransplantation. We have found a profound difference in cadaver kidney regraft survival associated with the age and sex of the donor. Kidneys from male cadaver donors yielded significantly higher graft survival rates than kidneys from female donors. The difference in graft survival at one year was 7% for all first transplants (n = 2974), 14% if the recipient was sensitized, and 18% in 688 patients being regrafted. The difference was even more striking in regraft recipients of kidneys from young male donors (72% one-year graft survival) as compared with recipients of kidneys from older female donors (44% one-year graft survival). The donor age and sex effects correlated well with the cause of donor death. Young male donors accounted for 59% of trauma deaths whereas older female donors made up only 7%. Nontrauma donors, on the other hand, were 38% older female and 14% younger male. The survival of trauma-death donor kidneys in regrafted patients was 69% at one year and 37% for nontrauma donor kidneys, a 32% difference (P less than 0.001). These results indicate that regraft survival could be significantly increased through the use of cadaver kidneys from trauma death donors.

Entities:  

Mesh:

Year:  1987        PMID: 3321589     DOI: 10.1097/00007890-198712000-00014

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  2 in total

1.  Transplantation and the trauma surgeon.

Authors:  P R Cunningham; M B Foil
Journal:  J Natl Med Assoc       Date:  1990-11       Impact factor: 1.798

2.  Organ procurement in patients with fatal head injuries. The fate of the potential donor.

Authors:  R C Mackersie; O L Bronsther; S R Shackford
Journal:  Ann Surg       Date:  1991-02       Impact factor: 12.969

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.